Pretreatment for Nerve Agent Poisoning

Chemical Warfare Agents: Toxicology and Treatment, Second Edition

Volumn , Issue , 2007, Pages 343-353

  Scott, Leah ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Physostigmine and hyoscine pretreatment; Pretreatment approach comparison; Pretreatments in nerve agent poisoning; Pyridostigmine pretreatment; Pyridostigmine pretreatment acceptability

Indexed keywords

EID: 40649110142     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470060032.ch17     Document Type: Chapter

References (42)

1. Anderson DR, Harris LW, Woodard CL et al. (1992). The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman or VX in rats. Drug Chem Toxicol, 15(4), 285-294.
2. Berry WK and Davies DR (1970). The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2,-trimethypropyl methylphosphonofluoridate. Biochem Pharmacol, 19, 927-934.
3. D'Mello GD, Duffy EAM and Miles SS (1985). A conveyor belt task for assessing visuo-motor coordination in the marmoset (Callithrix jacchus): Effects of diazepam, chlorpromazine, pentobarbital and damphetamine. Psychopharmacology, 86, 125-131.
4. D'Mello GD and Sidell FR (1991). A model for carbamate and organophosphate-induced induced emesis in humans. Neurosci Biobehav Rev, 15, 179-184.
5. Dirnhuber P, French MC, GreenDMet al. (1979). The protection of primates against soman poisoning by pretreatment with pyridostigmine. J Pharm Pharmacol, 31, 295-299.
6. Echobichon DJ and Comeau AM (1973). Pseudocholinesterases of mammalian plasma: physicochemical properties and organophosphate inhibition in eleven species. Toxicol Appl Pharmacol, 24, 92-100.
7. French M, Wetherell JR and White PD (1979). The reversal by pyridostigmine of neuromuscular block produced by soman. J Pharm Pharmacol, 31, 290-294.
8. Friedman A, Kaufer D, Shemer J. et al. (1996). Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nature Med, 2, 1382-1384.
9. Golomb BA (1999). A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Volume 2, Pyridostigmine Bromide. Rand Corporation: (http://www.gulflink.osd.mil/library/randrep/pb paper/or www.rand.or/pubs/monographreports/MR1018.2/).
10. Gordon JJ, Leadbeater L and Maidment MP (1978). The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol Appl Pharmacol, 43, 207-216.
11. Grauer E, Alkali D, Kapon J et al. (2000). Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Toxicol Appl Pharmacol, 164, 301-304.
12. Green DM and Smith AP (1983). The reversal by pyridostigmine of soman induced neuromuscular blockade in primate respiratory muscle. Br J Pharmacol, 79, 252P.
13. Harris L, Lennox W, Talbot BG et al. (1984). Toxicity of anticholinesterases; interaction of pyridostigmine and physostigmine with soman. Drug Chem Toxicol, 7, 507-526.
14. Harris LW, Talbot BG, Lennox WJ et al. (1991). Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication. Drug Chem Toxicol, 14, 265-281.
15. Hornby RJ, Pearce PC, Bowditch AP et al. (2006). Multiple Vaccine and Pyridostigmine bromide interactions in the common marmoset Callithrix Jacchus: Immunological and endochrinological effects. Int Immunopharmacol, 6, 1765-1779.
16. Inns RH and Leadbeater L (1983). The efficacy of bispyridinum derivatives in the treatment of organophosphonate poisoning in the guinea-pig. J Pharm Pharmacol, 35, 427-433.
17. Kluwe WM, Chinn JC, Feder P et al. (1987). Efficacy of pyridostigmine pretreatment against acute soman intoxication in a primate model. In: Sixth Medical Chemical Defense Bioscience Review, pp. 227-234. Aberdeen Proving Ground, MD, USA: US Army Medical Research Institute of Chemical Defense.
18. Koplovitz I, Gresham V, Dochterman LW et al. (1992a). Evaluation of the toxicity, pathology and treatmenyt of cyclohexylmethylphosphonofluoridate poisoning in rhesus monkeys. Arch Toxicol, 66, 622-628.
19. Koplovitz I, Harris L, Anderson DR et al. (1992b). Reduction by pyridostigmine pretreatment of the efficacy of atropine and 2-PAM treatment of sarin and VX poisoning. Fund Appl Toxicol, 18, 102-106.
20. Koster R (1956). Synergisms and antagonisms between physostigmine and diisopropyl fluorophosphates in cats. J Pharmacol Exp Ther, 88, 39-46.
21. Lallement G, Foquin A, Baubuchon D et al. (1998). Heat stress, even extreme, does not induce penetration of pyridostigmine into the brain of guinea-pigs. NeuroToxicology, 19, 759-766.
22. Leadbeater L, Inns RH and Rylands JM (1985). Treatment of poisoning by soman. Fund Appl Toxicol, 5, S225-S231.
23. Levy A, Brandeis R, Treves TAet al. (1994). Transdermal physostigmine in the treatment of Alzheimer's Disease. Alzheimer Dis Assoc Disord, 8, 15-21.
24. Lim DK, Ito Y, Yu ZJ et al. (1987). Prevention of soman toxicity after the continuous administration of physostigmine. Pharmacol Biochem Behav, 31, 633-639.
25. Lim DK, HoskinsBand Ho IK (1991). Triexyphenidyl enhances physostigmine prophylaxis against soman poisoning in guinea-pigs. Fund Appl Toxicol, 16, 482-489.
26. Maxwell DM, BrechtKMand O'Neill BL (1987). The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol Lett, 39, 35-42.
27. Meshulam Y, Davidovici R, Wengier A et al. (1995). Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea-pigs. J Appl Toxicol, 15(4), 263-266.
28. Miller SA, Blick DW, Kerenyi SZ et al. (1993). Efficacy of physostigmine as a pretreatment for organophosphate poisoning. Pharmacol Biochem Behav, 44, 343-347.
29. Muggleton NG, Bowditch AP, Crofts HS et al. (2003). Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus). Psychopharmacology, 166, 212-220.
30. Phillipens IHCM, Busker RW, Wolthius OL et al. (1988). Subchronic physostigmine pretreatment in guinea-pigs: effective against soman and without side effects. Pharmacol Biochem Behav, 59, 1061-1067.
31. Phillipens IHCM, Melchers BPC, Olivier B et al. (2000). Scopolamine augments the efficacy of physostigmine against soman poisoning in guineapigs. Pharmacol Biochem Behav, 65, 175-182.
32. Ridley RM, Bowes PM, Baker HF et al. (1984). An involvement of acetylcholine in object discrimination learning and memory in the marmoset. Neuropsychologia, 22, 253-263.
33. Rusted JM and Warburton DM (1988). The effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology, 96, 145-152.
34. Scott L (1996). Extrapolation of animal data to man: issues for consideration. In: Proceedings of the CB Medical Treatment Symposium,Vol. 2, p. 86. Spiez, Switzerland.
35. Scott EAM, Hollands RN and Wetherell JR (1994). The currentUKmedical countermeasures for nerve agent poisoning; Physostigmine and hyoscine as an alternative to pyridostigmine. In: Proceedings of the CB Medical Treatment Symposium, Vol. 1, pp. 1.14-1.17.
36. Sterri S and Fonnum F (1989). Carboxylesterase -the soman scavenger in rodents: heterogeneity and hormonal influence. In: Enzymes Hydrolysing Organophosphorous Compounds (E Reiner, WN Aldridge and FCG Hoskinn, eds), pp. 155-164. Chichester, UK: Ellis Harwood.
37. Warburton DM and Brown K (1972). The facilitation of discrimination performance by physostigmine sulphate. Psychopharmacology, 27, 275-284.
38. Watts P and Wilkinson RG (1977). The interaction of carbamates with acetylcholinesterase. Biochem Pharmacol, 26, 757-761.
39. Wetherell A (1992). Effects of physostigmine on stimulus encoding in a memory-scanning task. Psychopharmacology, 109, 198-202.
40. Wetherell JR (1994). Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning. J Pharm Pharmacol, 46, 1023-38.
41. Wetherell J, Hall T and Passingham S (2002). Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig. NeuroToxicology, 23, 341-349.
42. Wetherell JR, Price M and Mumford H(2006).Anovel approach for medical countermeasures to nerve agent poisoning in the guinea-pig. NeuroToxicology, 27(4), 485-491.